Skip to main content
Log in

Effects of antipsychotic medication on the movement pathologies of chronic schizophrenics

  • Published:
American Journal of Dance Therapy Aims and scope Submit manuscript

Abstract

Characteristics movement pathology as symptomatic of schizophrenia has long been cited in the literature. This pilot study postulates that these movement features are particular to the illness and distinct from medication side-effects. In conjunction with the National Institute of Mental Health's study on individual responsiveness of schizophrenics to neuroleptics, this study compared movement pathology across neuroleptic and placebo conditions. The videotapes of seven subjects were analyzed according to the Movement Diagnostic Scale, Version B. Of the five movement features postulated to be symptomatic of schizophrenia, and therefore predicted not to differ across medication conditions, ‘integration,’ ‘posture/locomotion,’ and ‘spatial complexity’ showed significant differences. Of the three movement features predicted to reflect medication effect, only ‘mobility’ was found to be significantly different. The results support a relationship between ‘fragmentation’ and large number of hospitalizations. Hence, the study suggests that some extrapyramidal effects of neuroleptic medication remain unrecognized and that the distinction between motor symptoms related to the illness or due to neuroleptics is blurred.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • American Psychiatric Association. (1987).Diagnostic and statistical manual III-R. Washington, DC.

  • Ban, T.A. (1972).Schizophrenia: A psychopharmacological approach. Springfield, Illinois: Charles C. Thomas.

    Google Scholar 

  • Bartholini, G. (1981). Mode of action of neuroleptic drugs. In H.M. van Pragg, M.H. Lader, O.J. Rafaelsen, & E.J. Sachar (Eds.),Handbook of biological psychiatry: Part IV. Brain mechanisms and abnormal behavior (pp. 767–804). New York: Marcel Dekker.

    Google Scholar 

  • Bellak, L. (Ed.). (1958).Schizophrenia. New York: Logos Press.

    Google Scholar 

  • Berger, P.A., & Davis, K.L. (1972). Pharmacological studies of tardive dyskinesia: Implications for furture research. In C.F. Baxter & T. Melnechuk, (Eds.),Perspectives in schizophrenic research (pp. 331–336). New York: Raven Press.

    Google Scholar 

  • Bigelow, L.B., & Wyatt, R.J. (1981).Effects of neuroleptic withdrawal in chronic schizophrenia. Unpublished proposal. National Institute of Mental Health, Adult Psychiatry Branch, Division of Special Mental Health Research, Intramural Research Program, Saint Elizabeths Hospital, Washington, D.C.

  • Bleuler, E. (1950).Dementia praecox, or the group of schizophrenias (J. Zinkin, Trans.). New York: International Universities Press.

    Google Scholar 

  • Byck, R. (1975). Drugs and the treatment of psychiatric disorders. In L.S. Goodman & A. Gilman (Eds.),The pharmacological basis of therapeutics (5th ed.) (pp. 152–200). New York: MacMillan.

    Google Scholar 

  • Condon, W.S. (1968). Linguistic-kinesic research and dance therapy.Proceedings of the Third Annual Conference of the American Dance Therapy Association, October 25–27, 1968, 21–42.

  • Davis, M. (1981). Movement characteristics of hospitalized psychiatric patients.American Journal of Dance Therapy, 4(1), 52–71. (Original work published 1970)

    Google Scholar 

  • —— (1972).Research approaches to movement and personality. New York: Arno Press.

    Google Scholar 

  • Freeman, T., Cameron, J.L., & McGhie, A. (1958).Chronic schizophrenia. New York: International Universities Press.

    Google Scholar 

  • Goodman, L.S., & Gilman, A. (Eds.) (1980).The pharmacological basis of therapeutucs (5th ed.). New York: MacMillan.

    Google Scholar 

  • Grinspoon, L., Ewalt, J.R., & Shader, R.I. (1972).Schizophrenia: Pharmacotherapy and psychotherapy. Baltimore: MD: Williams & Wilkins.

    Google Scholar 

  • Julien, R.M. (1975).A primer of drug action. San Francisco: W.H. Freeman.

    Google Scholar 

  • Kelly, D.H.W., & Sargant, W. (1963). Present treatment of schizophrenia—a controlled follow-up study.British Medical Journal, 1, 147–150.

    Google Scholar 

  • Kraeplin, E. (1971).Dementia praecox and paraphrenia (R.M. Barclay, Trans.). Huntington, NY: Robert E. Krieger. (From 1919 English translation)

    Google Scholar 

  • Marsden, C.D., Tarsey, D., & Baldessarini, R.J. (1975). Spontaneous and drug-induced movement disorders in psychotic patients. In D.F. Benson & D. Blumer (Eds.),Psychiatric aspects of neurologic disease (pp. 219–266). New York: Grune & Stratton.

    Google Scholar 

  • Reich, W. (1961).Character-analysis (T.P. Wolfe, Transl). New York; Noonday Press, a subsidiary of Farrar, Straw & Cudahy. (Original work published 1949)

    Google Scholar 

  • Sargant, W., & Slater, E. (1963).An introduction to physical methods of treatment in psychiatry Edinburg: Livingstone.

    Google Scholar 

  • Scheflen, A.E. (1981).Levels of schizophrenia. New York: Brunner/Mazel.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilder, V.N. Effects of antipsychotic medication on the movement pathologies of chronic schizophrenics. Am J Dance Ther 10, 77–94 (1987). https://doi.org/10.1007/BF02251790

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02251790

Keywords

Navigation